FOLH1 and posterior cortical atrophy: In recurrent PCa patients after surgery, PSMA-PET could be used to select specific and personalized treatments and should be considered as a prognostic parameter in patients who received previous salvage treatments, since a positive scan is associated with shorter PFS, MFS, and CRPC-FS.